SCHEMBL465896

SCHEMBL465896

C=CCCCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 1.00
ABCC4 O15439 1/20 1.00
LMNA P02545 4/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
ALDH1A1 P00352 2/20 0.57
TERT O14746 3/20 0.54
PTPN1 P18031 3/20 0.54
PPARG P37231 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
F7 P08709 2/20 0.54
F3 P13726 2/20 0.54
GMNN O75496 1/20 0.54
USP2 O75604 1/20 0.54
CYP1A2 P05177 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4364731 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL2798059 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL3124997 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL2492081 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
Undecylenic Acid SCHEMBL4464618 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
Undecylenic Acid SCHEMBL5974072 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL7576245 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
Undecylenic Acid SCHEMBL17827 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL481539 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1
SCHEMBL466094 1.00 MAPT (1.00) MAPTABCC4LMNATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260048043-A1 HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY INTELGENX CORP (CA) 2026-02-19 US claimed
EP-4568671-A1 HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY Intelgenx Corp. (CA) 2025-06-18 EP claimed
CN-119977504-A Micro-expansion grouting material with superfine powder to replace cement and preparation method thereof 安徽东材材料科技有限公司 2025-05-13 CN claimed
CN-119977707-A Multi-effect soil conditioner for organic matter polluted soil and preparation method thereof 东北农业大学 2025-05-13 CN claimed
CN-119866218-A High load oral film formulation with improved bioavailability 英特金思公司 2025-04-22 CN claimed
CN-118325203-B Wear-resistant sole material and preparation method thereof 南京奥瑞斯安全技术有限公司 2024-12-10 CN claimed
CN-118440445-A Modified plastic master batch and preparation method thereof 安徽九牛塑业科技有限公司 2024-08-06 CN claimed
CN-118390081-A Direct-current electrolysis method for multifunctional organic acid 浙江大学 2024-07-26 CN claimed
CN-118325203-A Wear-resistant sole material and preparation method thereof 南京奥瑞斯安全技术有限公司 2024-07-12 CN claimed
CN-118307789-A Resin microsphere for blood perfusion and preparation method and application thereof 河南驼人医疗器械研究院有限公司 2024-07-09 CN claimed
EP-1368411-A1 PHOTOACTIVE POLYMER Rolic AG (CH) 2003-12-10 EP claimed
EP-1277770-A1 Photoactive materials Rolic AG (CH) 2003-01-22 EP claimed
WO-2002062873-A9 PHOTOACTIVE POLYMER ROLIC AG (CH) 2002-10-03 WO claimed
WO-2002062873-A1 PHOTOACTIVE POLYMER ROLIC AG (CH) 2002-08-15 WO claimed
EP-1229066-A1 Photoactive polymer Rolic AG (CH) 2002-08-07 EP claimed
US-5859123-A ONE-PACKAGE PAINTS; PREPARED BY POLYMERIZING A FLUOROOLEFIN, AN ORGANOSILICON COMPOUND, AN UNSATURATED CARBOXYLIC ACID, AND A COPOLYMERIZABLE MONOMER CENTRAL GLASS COMPANY, LIMITED (JP) 1999-01-12 US claimed
US-4978525-A APPLYING A FATTY ACID (OR A FATTY ACID ESTER) TO THE SCALP SANSHO SEIYAKU CO., LTD. (JP) 1990-12-18 US claimed
EP-0099572-B1 DISPROPORTIONATION OF FUNCTIONAL OLEFINS PHILLIPS PETROLEUM COMPANY (US) 1989-09-06 EP claimed
US-4560792-A WITH HYDROCARBYL MONOOLEFIN IN PRESENCE OF TUNGSTEN CARBENE COMPLEX AND HALIDE(OR OXYHALIDE)CATALYST PHILLIPS PETROLEUM COMPANY (US) 1985-12-24 US claimed
EP-0099572-A1 Disproportionation of functional olefins PHILLIPS PETROLEUM COMPANY (US) 1984-02-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048043-A1 HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY MUC1, TAS2R42, MTX2 MAPT 2009/4885ABCC4 795/4885LMNA 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.